The attaching and effacing Escherichia coli (AEEC) are characterized by the presence of a type III secretion system encoded by the locus of enterocyte effacement (LEE). Enterohemorrhagic E. coli (EHEC) are often identified as isolates that are LEE+ and carry the Shiga toxin (stx)-encoding phage, which are labeled Shiga toxin-producing E. coli; whereas enteropathogenic E. coli (EPEC) are LEE+ and often carry the EPEC adherence factor plasmidencoded bundle-forming pilus (bfp) genes. All other LEE+/bfp−/ stx− isolates have been historically designated atypical EPEC. These groups have been defined based on the presence or absence of a limited number of virulence factors, many of which are encoded on mobile elements. This study describes the comparative analysis of the genomes of 114 LEE+ E. coli isolates. Based on a wholegenome phylogeny and analysis of type III secretion system effectors, the AEEC are divided into five distinct genomic lineages. The LEE+/stx+/bfp− genomes were primarily divided into two genomic lineages, the O157/O55 EHEC1 and non-O157 EHEC2. The LEE+/bfp+/stx− AEEC isolates sequenced in this study separated into the EPEC1, EPEC2, and EPEC4 genomic lineages. A multiplex PCR assay for identification of each of these AEEC genomic lineages was developed. Of the 114 AEEC genomes analyzed, 31 LEE+ isolates were not in any of the known AEEC lineages and thus represent unclassified AEEC that in most cases are more similar to other E. coli pathovars than to text modification AEEC. Our findings demonstrate evolutionary relationships among diverse AEEC pathogens and the utility of phylogenomics for lineage-specific identification of AEEC clinical isolates.
T he attaching and effacing Escherichia coli (AEEC) are a significant, yet diverse group of pathogenic organisms that cause human disease (1) . The AEEC pathogens include isolates defined by the presence of the locus of enterocyte effacement (LEE), encoding a type III secretion system (T3SS), responsible for the injection of effectors that result in the formation of attaching and effacing lesions (1) (2) (3) . Within this group of pathogens are the subgroups or pathovars known as enterohemorrhagic E. coli (EHEC) and the enteropathogenic E. coli (EPEC). Both EHEC and EPEC have been associated with severe disease and high mortality rates (4) . The EHEC are defined on the molecular level as LEE-positive, Shiga toxin-encoding E. coli based on the presence of the Shiga toxin genes (stxAB). As such, EHEC are a subset of Shiga toxin-producing E. coli (STEC) strains, which are defined solely by the presence of stxAB without regard to LEE status. Genome sequencing of AEEC pathogens has largely focused on the O157:H7 EHEC (5-9), which are a significant cause of severe gastrointestinal illness and hemolytic uremic syndrome (HUS) in the United States (10, 11) . The O157:H7 EHEC [LEE+/stx+/bundle-forming pilus-negative (bfp−) AEEC] are hypothesized to have evolved from LEE+/stx−/bfp− O55:H7 by the stepwise acquisition of virulence factors (12) (13) (14) (15) (16) . To date, only a few non-O157 EHEC/STEC genomes have been sequenced (17, 18) . One noticeable exception is the rapid sequencing and analysis of the O104:H4 E. coli outbreak isolates from the 2011 European outbreak (19) (20) (21) . Although the bacterium implicated in the outbreak contained more genomic similarity to enteroaggregative E. coli (EAEC) isolates than EHEC isolates, the presence of the Shiga toxin-encoding genes and the clinical presentation of HUS led to confusion related to how to accurately classify this organism (19) (20) (21) (22) . These studies demonstrated the utility of whole-genome sequencing in outbreak situations, as well as the requirement for proper reference genomes for comparison.
The AEEC subgroup known as EPEC is a significant cause of persistent watery diarrhea among children worldwide (23) . EPEC isolates belonging to a limited number of O:H serotypes (24) contain the LEE region and may contain the EPEC adherence factor (EAF) plasmid-encoding genes encoding the bundle-forming pilus (bfpA-bfpL) (1, 2, 25, 26) . The LEE+/ stx−/bfp+ AEEC isolates are classified as typical EPEC (tEPEC), whereas the LEE+/stx−/bfp− AEEC isolates are termed atypical EPEC (aEPEC). The LEE+/stx−/bfp− AEEC isolates have been characterized as highly heterogenous, and likely include isolates that were once stx+ EHEC or bfp+ tEPEC isolates, but have lost those features during culture or passage (27, 28) . Indeed, stx− isolates cultured from HUS patients have been thought to have lost the Shiga toxin phage during the course of the infection or isolation (29, 30) . Meanwhile, the loss of the EAF plasmid from tEPEC has been observed following the passage of EPEC through adults in clinical trials (31, 32) . This level of heterogeneity is often observed when the lack of certain virulence factors or genomic features is used as an identifying characteristic, especially when mobile genetic elements such as bacteriophages or plasmids encode these factors (13) (14) (15) (16) . There is sparse information about the genomic distribution of EPEC, with only one genomic representative of each of the two major lineages of tEPEC from humans, one rabbit-adapted EPEC (E22), and one aEPEC representative (E110019) sequenced to date (33, 34) . Although these isolates are excellent starting points for functional analysis, they do not provide enough information to properly describe the genomic diversity of this pathogenic group.
In the current study, we demonstrate the diversity of AEEC pathogens using genome sequencing and comparative analysis of 114 AEEC isolates as well as a diverse collection of 24 reference commensal and pathogenic E. coli and Shigella (34). The 114 AEEC genomes include 101 genome sequences that are first analyzed in this study. Among the isolates sequenced were 35 AEEC isolates of the diarrheagenic E. coli (DEC) collection, which provide a link to established reference isolates used in the community (35) . The remaining AEEC isolates sequenced in this study were selected to represent a diverse set of diarrheagenic LEE+ isolates that have a wide array of serotypes, geographic locations, and isolation dates. Phylogenomic comparisons demonstrate that the AEEC can be separated into at least five distinct lineages, each with five or more isolates. A whole-genome comparative approach identified regions that are overrepresented or exclusive in subgroupings of the AEEC isolates. Molecular assays targeting these novel regions were then developed to identify each of these phylogeny-based lineages. Additional bioinformatic analysis of type III secretion effector proteins and other virulence-associated genomic islands, demonstrated that some features are lineage restricted in a pattern that is consistent with the whole-genome phylogeny. Importantly, and reminiscent of the recent German outbreak caused by a Shiga toxin-containing O104:H4 EAEC isolate (19) (20) (21) (22) , our findings demonstrate that the stx-encoding phage is not restricted to specific AEEC lineages. Multiple examples of isolates that contain inconsistent virulence gene and phylogenetic markers were identified in the same phylogenomic lineage, demonstrating a greater genomic variation in these isolates than was previously appreciated. The detection of the lineage-specific markers should be used concurrently with virulence gene detection to assess not only the pathogenic potential, but also the potential evolutionary history of LEE-containing E. coli.
Results and Discussion
Phylogenomic Analysis of AEEC. The whole-genome alignment (WGA) phylogenetic method has been used to accurately determine evolutionary relationships of E. coli (36) or other closely related species (37) . Using the phylogenetic information included in the core genome alignment containing 2.5 Mbp of the 138 genomes included in this study (Dataset S1), we determined that AEEC genomes are represented in each of the previously defined E. coli phylogenetic groups (A, B1, B2, D, E, F) (38-40) (Fig. 1) . There is significant congruence between the previously identified multilocus sequence typing (MLST) schema (41, 42) (Fig. S1 ) and the current whole-genome phylogeny (Fig. 1) , but there are noticeable differences. One significant difference is the topology of the EPEC in the B2 phylogroup, especially the EPEC4 lineage in relation to the EPEC and uropathogenic E. coli (UPEC) lineages in the MLST versus whole-genome analyses ( Fig. 1 and Fig. S1 ).
The whole-genome phylogeny grouped what was classically referred to as EHEC isolates into two lineages; the first lineage (EHEC1) contains two subgroups that are closely related, O157 STEC/AEEC and O55 AEEC, and a second more divergent lineage (EHEC2) that can best be described as non-O157 STEC/ AEEC (Fig. 1) . The O157 STEC/AEEC and O55 AEEC are so similar that complete gene-based differences could not distinguish them based on the core genome alignments. However, there are differences in the secreted effector profiles (see below), and single-nucleotide methodologies have been previously identified that are adequate for differentiation (5) (6) (7) (8) (9) . For the purposes of this study, we group the O157 and O55 isolates together. Not surprisingly, there are isolates in each of the EHEC lineages that are either Shiga toxin positive or negative, highlighting the notion that the genomic comparisons are more robust in classification and informative for phylogeny than typing isolates based on virulence factors encoded on mobile elements.
The classical definition of EPEC is LEE region positive (LEE+) and stx negative; tEPEC strains are also bfp positive (bfp+) (1, 2). Additional criteria for classifying isolates as EPEC include the detection of specific serogroups (24, 28, (43) (44) (45) . By MLST, EPEC have been demonstrated to cluster in two main lineages, previously designated EPEC1 and EPEC2 (42, 46) . The EPEC1 lineage is in the E. coli phylogroup B2 ( Fig. 1 ) and the majority carry the fliC-H6 gene (encoding the flagella type H6). Interestingly, the EPEC2 genomes form a monophyletic group in E. coli phylogroup B1 and all encode the fliC-H2 gene, which was Fig. 1 . Phylogenomic analysis of a collection of AEEC isolates. Phylogenomic analysis of 114 AEEC genomes and a collection of 24 representative E. coli and Shigella genomes that have been previously published. All genomes were aligned using Mugsy (64) and homologous blocks were concatenated. A phylogenetic tree was inferred with RAxML, version 7.2.8 (65), on this alignment, with 100 bootstrap replicates. Letters at nodes indicate the E. coli phylogroup. The strain names are color-coded by AEEC lineage and the E. coli and Shigella reference genomes are indicated in black. A star symbol designates the presence of the bundle-forming pilus pilin gene, bfpA, while a "+" symbol designates the presence of a Shiga-toxin gene (stx1 and/or stx2). Nodes that have bootstrap support ≥90 are indicated by a shaded circle.
found to be the lineage specific biomarker for EPEC2 (see below and Dataset S2). EPEC2 genomes are more evolutionarily similar to the non-O157 STEC/AEEC (EHEC2) lineage than to the EPEC1. There are also tEPEC (LEE+/stx−/bfp+) isolates previously identified as EPEC4 by MLST (Fig. S1B ) that are more similar to LEE− E. coli such as the commensal/laboratory adapted, UPEC and EAEC in the whole-genome phylogeny than they are to other EPEC (Fig. 1) .
The LEE+/stx−/bfp− E. coli isolates would have traditionally been considered aEPEC; however, based on phylogenomic analysis, these isolates are genomically diverse and many are more similar to E. coli of other pathovars ( Fig. 1 and Fig. S2A ), as well as the tEPEC lineages. These relationships suggest that distinct EPEC lineages may have arisen multiple times from horizontal transfer of the LEE region into diverse E. coli backbones. There were 71 genomes in this study that had neither the stx nor bfp genes [based on a BLAST score ratio (BSR) threshold of >0.8] and confirmed by PCR detection that would have traditionally been classified as aEPEC. Based on whole-genome phylogenetic analysis, 35% (25 of 71) of these isolates could be placed into the EPEC1, EPEC2, or EPEC4 lineages, suggesting that they may have lost the EAF plasmid. Interestingly, within the EPEC2 clade, there are two isolates that are LEE+/stx+/bfp−. The isolate 12009 (serotype O103:H2), was previously characterized as an stx1/stx2-positive non-O157 EHEC (17) and the isolate DEC11C (serotype O45:H2) as stx1+ non-O157 EHEC; however, both isolates have a chromosomal composition that is more similar to EPEC2 based on the whole-genome phylogeny. Furthermore, the H.I.8. isolate [recently reserotyped as O89:H2 (47)] possesses both the EAF plasmid and the Shiga toxin Stx2f (48, 49) , serving as an example of a hybrid virulence gene combination that does not fit the classical identification scheme (Fig.  S2A) . These three examples highlight the incongruence of the virulence factor-based typing schema and the dissociation between the genome content and virulence gene content that can be explained by transfer of mobile genetic DNA carried by different Stx-encoding bacteriophages in closely related bacteria.
The genome sequencing of additional LEE+/stx−/bfp+ AEEC isolates may lead to the characterization of new phylogenomic lineages of EPEC. The current analysis takes a conservative approach by not designating additional clade numbers on groups of isolates that contain less than five members, but we also realize that, in the current structure, there is the possibility to add clades to this analysis. The possibility of additional EPEC lineages is suggested by the presence of two bfp+ isolates that are not in the EPEC1, EPEC2, or EPEC4 lineages. None of the genomes sequenced in the present study are similar to isolates of the previously defined EPEC3, which was identified by MLST (42) . Overall, these analyses provide a framework for the continued genome-scale examination of the AEEC.
Large-Scale BSR Analysis. By sequencing a large number of closely related isolates from known geographic and temporal locations, we can begin to examine the presence and absence of genomic features from an epidemiological perspective. To globally identify all differentially present genomic features, a large-scale BSR (LS-BSR) method was developed extending from the basic BSR analysis (50) . A comparison of average BSR values across each genomic region identified several genomic features that are more prevalent in specific groups or lineages, such as all EPEC lineage genomes compared with all EHEC lineage genomes (Dataset S3). For this analysis, we used a threshold of the LS-BSR being greater than 0.8 in all target genomes and less than 0.4 in all nontarget genomes to identify features that occur primarily in genomes of one group compared with another group (Dataset S2). There was only one feature (sroH) present in the majority of the EHEC lineage genomes (both O157/O55 AEEC/EHEC1 and non-O157 EHEC2 lineages) that were absent from all of the EPEC lineage genomes (EPEC1, EPEC2, and EPEC4), compared with four features (alsC, rpiR, yjcX, and rpiB) in the EPEC lineage genomes that were absent from the EHEC lineage genomes ( Fig. 2A and Dataset S3). Most of these genes encode hypothetical proteins (Dataset S3). This paucity of universal, pathotype-specific features is consistent with our thesis that traditional classification schemes do not accurately reflect overall genetic similarity.
Although there were a limited number of genomic differences between all EPEC and all EHEC lineage genomes, there were considerably more intrapathovar differences. The LS-BSR comparison of the genome from isolates in the EPEC1 and EPEC2 clades demonstrates that there were 190 features unique to EPEC1 compared with 261 features unique to genomes of the EPEC2 lineage (Fig. 2B) . As discussed previously, the comparison of O157 EHEC to O55:H7 AEECs of the EHEC1 genomic lineage (Dataset S3) demonstrated more similarity between these genomes than between the O157 genomes of the EHEC1 Fig. 2 . Large-scale BLAST score ratio (LS-BSR) analysis of AEEC genomes. LS-BSR analysis was performed on the 114 AEEC genomes analyzed in this study as previously described (66) . A plot of BSR values for each genomic feature considered in this study averaged across genomes present in the specific lineages being compared. Features that are differentially conserved in each group are outlined in black; annotations for differential features are shown in Dataset S2: (A) a comparison of average BSR values for each genomic feature between all EHEC lineage genomes (EHEC1 and EHEC2) and all EPEC lineage genomes (EPEC1 and EPEC2), and (B) a comparison of average BSR values between the EPEC1 and EPEC2 phylogenomic lineages.
lineage and non-O157 genomes of the EHEC2 lineage (Dataset S3), which is also reflected in the whole-genome phylogeny (Fig.  1) . These findings suggest that the high-throughput method of identification of these features is valid and the regions identified may play previously unknown roles in the different virulence properties of the isolates of these pathovars.
The new sequencing technologies have provided us with a wealth of genomic information; however, the associated largescale comparative bioinformatic analyses have lagged behind. The LS-BSR method described here provides a rapid way for the identification of genome regions that are more or less prevalent in any group pairwise comparison. For example, isolates from a severe clinical outcome and asymptomatic infection can be compared to identify whether there are genomic regions that are potentially responsible for the observed clinical outcome. These types of analyses will be required in the future when hundreds or thousands of isolates are sequenced for clinical diagnosis.
Virulence Factors of AEEC Isolates. The genes of the LEE pathogenicity island are the defining feature of the AEEC pathogens (1, 3) . In particular, eae-encoding intimin, is frequently detected by PCR as a diagnostic method, and allelic typing of the intimin gene (51) has been proposed as an indicator of whether an isolate would likely be able to cause human illness (52) . In silico comparison by BSR analysis of the LEE region for the AEEC genomes demonstrated lineage-specific levels of similarity (Fig.  S3) . However, an eae phylogeny (Fig. S4 ) exhibited incongruence compared with the phylogenomic analysis of these genomes (Fig.  1) . This is consistent with previous observations that the LEE region has been acquired by multiple distinct lineages of E. coli leading to the emergence of diverse AEEC isolates (42) . However, in the current phylogenomic analysis, we demonstrate that the LEE has been acquired by E. coli with exceptional diversity including isolates that are more related to other pathogenic E. coli than to the previously characterized lineages of EPEC and EHEC (Fig. 1) . Although the LEE pathogenicity island is primarily linked with the evolutionary history of many of the AEEC genomes, this region may be subject to more widespread horizontal gene transfer than previously demonstrated (42, 53) .
Additional virulence-associated regions of the AEEC genomes exhibited lineage-specific patterns of distribution. The pathogenicity island, O-island 122 (OI-122), has been associated with AEEC clinical isolates that cause more severe illness (6, 54, 55) . All three modules of OI-122 were identified in nearly all genomes of the EHEC1 lineage, whereas most genomes of the EHEC2 lineage had modules 2 and 3 but were missing module 1 (Fig. S5) . Another region with a lineage-specific distribution is a genomic island encoding type VI secretion system genes (T6SS). T6SS genes have been linked to pathogenicity in enteric bacteria (56) and have been previously detected in diverse E. coli by in silico analysis (57, 58) , although the association of this region with virulence in AEEC is not known. As demonstrated by the LS-BSR analysis, T6SS genes were among those genes present in EPEC2 lineage genomes but absent from the EPEC1 genomes (Dataset S3). In silico detection using BSR verified the presence of T6SS genes in genomes of the EHEC1, EHEC2, and EPEC2 lineages, and select unclassified AEEC genomes (Dataset S1). These T6SS genes were primarily identified within close proximity to the aspV tRNA gene, although the EPEC2 genomes were found to have two distinct T6SS gene clusters, one located near aspV and a second near the metV tRNA gene (Dataset S1). The role of the T6SS in these pathogens is currently unconfirmed.
Type III Secreted Effectors of AEEC. The T3SS encoded by the LEE pathogenicity island, and numerous non-LEE secreted effectors have been described for each pathovar (7, 59, 60) . A study by Tobe et al. (7) demonstrated that the O157:H7 strain Sakai contained 49 type III effectors and 13 pseudogenes that exhibit similarity to known secreted effectors. The 49 T3SS effectors of Sakai were detected with high identity in 50-100% of the O157: H7 EHEC1 genomes in this study (Dataset S4). The majority of the T3SS effectors of Sakai were also identified in the O55 AEEC genomes that form a closely related subgroup of the genomes in the EHEC1 lineage (Dataset S4). However, the effectors espN, espO1-2, nleG, espM1, espW, and espL4 were not detected with high identity in any of the O55 AEEC genomes of the EHEC1 genomic lineage (Fig. 3A and Dataset S4). Eight (espN, espO1-1, espO1-2, nleG, espM1, tccP, espW, espL4) of the 49 Sakai effectors were statistically (P < 0.05) more prevalent among the O157 EHEC1 genomes than the O55 EHEC1 genomes (Dataset S5). This result demonstrates the similarity between the O55 and O157 isolates of phylogroup E that form the EHEC1 genomic lineage (Fig. 1 ) but also indicates that there are differences between these groups of isolates in potentially relevant virulence gene prevalence. These regions were not identified in the WGA for use as distinguishing markers due to the similarity with other secreted effectors in the genomes from these pathogens. There were 32 Sakai effectors that were identified in one or more of the genomes of the EHEC2 lineage, and 25 of these effectors were present in more than one-half of the genomes belonging to this lineage (Dataset S4). However, 26 of the Sakai effectors were statistically (P < 0.05) more prevalent in O157 EHEC1 genomes than in genomes of the EHEC2 lineage (Dataset S5). The EPEC2 lineage genomes in this study contained 29 of the Sakai effectors in one or more of the genomes, including 16 that were detected with high identity in more than one-half of these genomes (Dataset S4). In contrast, only 14 of the 49 Sakai effectors were detected with high identity in more than one-half Fig. 3 . Comparison of the T3SS effector repertoire of AEEC isolates. BLAST score ratio (BSR) analysis (50) using TBLASTN (67) of predicted T3SS effector proteins that were previously characterized in the genomes of (A) the O157:H7 STEC strain Sakai of the EHEC1 lineage, and (B) EPEC1 strain E2348/69 and EPEC2 strain B171. The ratios were visualized with a color gradient ranging from 0 (blue) to 1 (yellow) using MeV (68, 69) . Hierarchical clustering of the BSR values was performed in MeV using the Pearson correlation coefficient (70) . Each square indicates the presence or absence of a single effector in one genome. Each column is a different genome and the phylogenomic lineage the isolates belong to are designated by the color of the last square at the bottom of each column. Each row represents a single T3SS effector. A star symbol identifies whether a genome contains the bundle-forming pilus gene, bfpA, whereas a "+" symbol designates the presence of a shiga toxin (stx1 and/or stx2).
of the genomes belonging to the EPEC1 lineage (Fig. 3 and Dataset S4) and only seven Sakai effectors were present with high identity in more than one-half of the EPEC4 genomes (Dataset S4). These findings demonstrate that the T3SS effectors from an O157:H7 genome of the EHEC1 genomic lineage exhibit greater similarity to effectors in genomes of the EHEC2 and EPEC2 lineages of phylogroup B1 than to the EPEC1 and EPEC4 lineages of phylogroup B2 (Figs. 1 and 3 , and Dataset S4). The role of each of these different effector protein profiles in pathogenesis is unclear but does provide additional biological markers of isolate similarity.
To further examine the secreted effector profiles, the additional 21 T3SS effectors and six effector pseudogenes identified in the EPEC1 prototype strain E2348/69 (33) and 26 predicted T3SS effectors and seven effector pseudogenes in the EPEC2 strain B171 (61) were added to the BSR comparisons with the EHEC effectors identified by Tobe et al. (7) . The genomes in the current study were examined with BSR for the presence or absence of these effectors that were identified in the EPEC1 reference genomes (33, 61) . Of the 21 T3SS effectors identified in E2348/69, there was one, nleE1, that was detected in less than one-half of the genomes in the EPEC1 lineage, suggesting either sequence divergence or the absence of this effector from some of the EPEC1 isolates ( Fig. 3B and Dataset S4). Eleven of the E2348/69 effectors were statistically (P < 0.05) more prevalent among the 14 genomes of the EPEC1 lineage than in the other 100 AEEC genomes analyzed in this study (Dataset S5). The other 10 E2348/69 effectors were identified in one or more of the other AEEC lineages, demonstrating that these effectors have less lineage-specific diversity (Datasets S4 and S5). Fourteen of the 21 E2348/69 effectors were detected in one or more isolates of the EPEC2 lineage, with 8 of these effectors being conserved in more than one-half of the EPEC2 isolates ( Fig. 3B and Dataset S4). The EPEC4 isolates contained 11 of the E2348/69 effectors, of which 9 were conserved and present in more than one-half of the EPEC4 isolates ( Fig. 3B and Dataset S4). Of the 26 T3SS effectors identified in the genome of the EPEC2 prototype isolate B171, there were 22 detected in more than onehalf of the genomes in the EPEC2 lineage ( Fig. 3B and Dataset S4). There were 15 of the B171 effectors detected in genomes of the EPEC1 lineage, of which 14 were present in more than onehalf of the EPEC1 genomes (Dataset S4). Thirteen of the B171 effectors were statistically (P < 0.05) more prevalent among genomes of the EPEC2 lineage than in all other AEEC genomes (Dataset S5).
LEE-encoded effectors were detected with high similarity (BSR ≥ 0.8 compared with reference collections of characterized effectors) in nearly all AEEC genomes analyzed ( Fig. 3A and Dataset S4). For example, the LEE-encoded effectors map and espG, from the B171 genome, were detected among nearly all (95-99%) of the AEEC genomes analyzed, demonstrating their high level of sequence conservation (Dataset S4). This result indicates that a core set of effector proteins is conserved in all AEEC isolates, whereas accessory effector proteins can be identified that are lineage specific. The cluster analysis of the T3SS effectors demonstrates that their prevalence and level of similarity can be correlated to phylogenetic lineage, which may be somewhat surprising as many effectors are associated with bacteriophage genomes (7, 62, 63) (Fig. 3) . This finding suggests that there is an evolutionary linkage between the genomic context and virulence genes. Although the effector profiles were somewhat distinctive, any one effector used in isolation could not fully represent the genomic or virulence factor lineages previously identified.
Conclusion
The classification of AEEC isolates to pathovars has previously depended on the detection of virulence genes present on mobile elements such as plasmid and phage; however, as was dramatically demonstrated with the German E. coli outbreak in 2011, new combinations of virulence genes can blur these classical definitions (20, 21) . Our findings establish the utility of comparative genomics to provide information regarding the evolutionary history of AEEC pathogens and provide insights into the evolutionary relationships of AEEC. The AEEC pathogen classification based on information derived from phylogenomics refines these pathovars as multiple distinct phylogenomic lineages. This study demonstrates that the classification of LEEpositive isolates lacking either stx or bfp as "aEPEC," provides an incomplete, and potentially misleading assumption of their evolutionary relationships and pathogenic potential. There are multiple examples of previous isolates being incorrectly categorized based on incomplete information or unstable genetic elements. It is possible that isolates lacking virulence-based markers encoded on mobile elements have lost those markers during transit in the host or associated culture, and thus the phylogenetic identification will provide additional information that can provide critical clinical information. It is likely that further sequencing of AEEC genomes will result in the description of novel AEEC lineages.
Phylogenomic analysis of a large number of AEEC clinical isolates, including a diverse set of non-AEEC E. coli has demonstrated that EHEC and EPEC have emerged in multiple lineages following the acquisition of the mobile elements such as a Stx phage or EAF plasmid. Therefore, classification of AEEC pathogens based on a singular approach such as serotyping, intimin-typing or by the detection of Stx phage or EAF plasmid genes is not sufficient to determine the evolutionary history of clinical isolates or their pathogenicity repertoire.
Materials and Methods
Isolates were chosen for sequencing from the DEC collection of the Statens Serum Institut (www.ssi.dk/English.aspx) based on the presence of the LEE pathogenicity island, and representing diverse serogroups. Genome sequencing was performed at the Institute for Genome Sciences, Genome Resource Center (www.igs.umaryland.edu/resources/grc/index.php) as described in SI Materials and Methods. Details of the assembly for each isolate are in Dataset S1. The whole-genome phylogenies were constructed by first aligning the final assemblies of all genomes using Mugsy (64) . Information about the whole-genome phylogenies, bioinformatics analyses of virulenceassociated genes, and development of lineage-specific markers for multiplex PCR analysis is provided in SI Text.
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